Navigation Links
Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
Date:3/13/2013

SAN DIEGO, March 13, 2013 /PRNewswire/ -- Receptos Inc. announced today that it has entered a Development License and Option Agreement to in-license a humanized anti-interleukin-13 (IL-13) antibody asset from AbbVie (NYSE: ABBV).

The asset, designated RPC4046 by Receptos, has completed a first-in-human Phase I study. Under the agreement, Receptos will conduct a Phase 2 clinical study to demonstrate proof-of-concept in Eosinophilic Esophagitis (EoE), an indication designated as an Orphan Disease by the US FDA. AbbVie holds an exclusive option to enter into a global co-development collaboration for RPC4046 with Receptos following results of the planned Phase 2 study and regulatory discussions with the FDA.

"We are honored that AbbVie has entrusted a promising Phase 2-ready therapeutic candidate to the Receptos development team to pursue proof-of-concept in EoE, an Orphan Disease growing in prevalence for which there are no approved treatment options," said Faheem Hasnain , President and Chief Executive Officer of Receptos. "We believe that AbbVie's exceptional track record in immunology will be a strong asset in this collaboration."

Upon exercise of the co-development option, AbbVie and Receptos would enter into a collaboration agreement in which the parties would equally share costs of the Phase 3 clinical program and future development on a global basis. Receptos would retain a right to co-promote RPC4046 and share equally in profits in the United States. Outside of the US, AbbVie would hold sole commercial rights and Receptos would be eligible for double digit royalties on net sales. Additional indications may be pursued under the collaboration, as the mechanism of action has been shown to have potential in various immunological and allergic disorders.

Should AbbVie decline to exercise its co-development option for RPC4046, Receptos would obtain a
'/>"/>

SOURCE Receptos Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Receptos Determines Novel GPCR Structure, Achieves Key Milestone in Collaboration with Ono Pharmaceuticals
2. Graham Cooper Appointed Chief Financial Officer of Receptos
3. Receptos to Present at the 2012 Wedbush PacGrow Life Sciences Management Access Conference
4. Receptos to Deliver Scientific Presentation at Digestive Disease Week 2012 about the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease
5. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
6. Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center
7. uniQure Licenses RNA Interference Technology to Advance Huntingtons Disease Program
8. Parios Regenerative Sciences, Inc. Licenses Exclusive Rights to Organic Nanotechnology for Skin Repair
9. West Health Institute licenses Kinect-based physical therapy technology to Reflexion Health; West Health Investment Fund makes $4.25 million investment
10. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
11. NTT DATA Licenses DATATRAK ONE™ for China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Egalet Corporation (Nasdaq: EGLT ) ... on developing, manufacturing and marketing innovative pain treatments, ... and chief executive officer, is scheduled to present ... an update on Egalet,s marketed product SPRIX ... product OXAYDO ™ (oxycodone HCI, USP) tablets ...
(Date:5/26/2015)... , UAE, May 26, 2015 ... Patient Care & Quality of Life Throughout Europe, the ... Africa    Astellas Pharma EMEA is ... the Company,s founding through the historic merger of Japanese ... last ten years, committed to turning science into value ...
(Date:5/22/2015)... 22, 2015  Research and Benchmarking firm, Best ... Medical Affairs Roundtable on Thursday, May 28th ... roundtable to discuss "Medical Affairs, Role in Health ... Medical Affairs Consortium provides Medical Affairs leaders with ... challenges they face. The consortium has developed a ...
Breaking Medicine Technology:Egalet to Present at Upcoming Conferences in June 2Egalet to Present at Upcoming Conferences in June 3Astellas Pharma EMEA Celebrates Its 10th Anniversary 2Astellas Pharma EMEA Celebrates Its 10th Anniversary 3Astellas Pharma EMEA Celebrates Its 10th Anniversary 4Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2
... organizations can now gain unmatched visibility into their business ... costs, ensure compliance, and improve financial performance with new ... Inc. (AIM: CRW.L; OTC: CRWRY), the leader in ... "Pharmacy revenue leakage costs hospitals millions," said Keith ...
... Pharmaceuticals, Inc., (Amex: AEN ) announced five ... zinc deficiency in Alzheimer,s disease and cognitive decline. The ... and consultant, George J. Brewer, M.D., the Morton S. ... Internal Medicine at the University of Michigan. ...
Cached Medicine Technology:Craneware's Pharmacy ChargeLink® Version 3 Helps Improve Margins and Control Costs 2Craneware's Pharmacy ChargeLink® Version 3 Helps Improve Margins and Control Costs 3Craneware's Pharmacy ChargeLink® Version 3 Helps Improve Margins and Control Costs 4Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimer's Disease and Cognitive Decline 2Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimer's Disease and Cognitive Decline 3Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimer's Disease and Cognitive Decline 4Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimer's Disease and Cognitive Decline 5
(Date:5/26/2015)... Boston, MA. (PRWEB) May 26, 2015 ... Standing option in their online Master of Social ... Program sites and on the Charles River Campus, the ... , This Advanced Standing option is open ... by the Council on Social Work Education. Students entering ...
(Date:5/26/2015)... 26, 2015 Carl W. Berk, M.D. ... Center in Pinehurst, N.C. have launched a Balloon Sinuplasty ... about chronic sinusitis and the benefits of Balloon Sinuplasty. ... used to determine if someone is a good candidate ... and other factors that can contribute to chronic nasal ...
(Date:5/25/2015)... La. (PRWEB) May 26, 2015 Author Vincent ... number of people today are overweight, and many of them ... health. He also knows that most people don’t realize the ... environmental hazards and man-made toxins that exist. There ... don’t realize exactly how serious tobacco is.” , In “ ...
(Date:5/25/2015)... (PRWEB) May 26, 2015 ... honors Dr. Heather Stanley-Christian as a ... Year Circle. She is recognized with this prestigious ... nation's leading networking organization exclusively for professional women, ... operating local chapters. , "I'm pleased to welcome ...
(Date:5/25/2015)... New York (PRWEB) May 25, 2015 ... of patented products, launches the Big Little Party Table, ... customize the perfect table that will suit their party ... whopping revenue of $646 billion this past year. ... year industry" says Scott J. Cooper, CEO and Creative ...
Breaking Medicine News(10 mins):Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 3Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 2Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 3Health News:NAPW Inducts Dr. Heather Stanley-Christian, Systems Chair/Maternal Fetal Medicine at Stroger Hospital, into Its VIP Professional Woman of the Year Circle 2Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 2Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 3
... HILL, N.C., Feb. 19 With sales forces ... the constant,demand for rep time, winning a place ... response, leading pharma companies are relying on,specialized training ... process within the hospital environment, according to recent,research ...
... WYE ),announced today that The Honorable Stuart R. ... Maryland, has granted Wyeth,s motion for,summary judgment in the ... al -- an alleged vaccine injury case claiming that ... autistic., Previously, the Court had granted Wyeth,s motion ...
... PARK, Fla., Feb. 19 Transitionz Wellness,Boutique is ... or adult, who,is a cancer survivor, is going ... is trying to get well, and we are ... of the best products and services,including wigs, hats, ...
... A new technique developed by a University of Central ... bacterial infections patients have so they can be treated ... strains resistant to many drugs emerge, it becomes more ... would most effectively treat them. Such quick identifications become ...
... new study released,today found that pending congressional legislation ... technologies would likely result,in increased prices and "provide ... released today at the National Press Club by ... and senior fellow at,the American Enterprise Institute, and ...
... response to recent media,reports, Roche would like to reaffirm ... medication for the 2007-2008,flu season, and that physicians and ... flu strikes., Some news reports have indicated "shortages" ... in place to ensure that Tamiflu is readily,available. If ...
Cached Medicine News:Health News:Building an Effective Sales Force to Serve the U.S. Hospital Market 2Health News:Wyeth Wins Thimerosal-Autism Case in Maryland Court 2Health News:Wyeth Wins Thimerosal-Autism Case in Maryland Court 3Health News:Transitionz Wellness Boutique Launches with Grand Opening Discounts 2Health News:UCF technique promises to aid doctor's ability to identify, treat bacterial infections 2Health News:New Report Finds Mandatory Price Disclosure for Med Tech Would Likely Increase Prices 2Health News:Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide 2
... new modular Endourological Platform concept, the ... developped in extracorporeal lithotripsy: electroconductivity, with ... Sonolith Praktis can easily be coupled ... and ultrasound scanners for accurate localization ...
Used for temporary control of male urinary incontinence due to surgery or neurogenic disorder. Supplied non-sterile. Reusable. Intended for single patient use only....
Used for male external catheterization due to urinary incontinence. The inflatable retention ring secures the catheter and can be easily deflated for removal. Supplied non-sterile. Reusable. Intended...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
Medicine Products: